Cargando…

Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19

Detalles Bibliográficos
Autor principal:	Moutsopoulos, Haralampos M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456551/ https://www.ncbi.nlm.nih.gov/pubmed/32345616 http://dx.doi.org/10.1136/annrheumdis-2020-217562

Ejemplares similares

COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

Rheumatology in Greece: pros and cons
por: Moutsopoulos, Haralampos M.
Publicado: (2020)

A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine
por: Moutsopoulos, Haralampos M.
Publicado: (2021)

Obituary for Joachim Robert Kalden
por: Moutsopoulos, Haralampos M.
Publicado: (2021)

Autoimmune rheumatic diseases: One or many diseases?
por: Moutsopoulos, Haralampos M.
Publicado: (2021)

Obituary for Efstratios (Stratis) Avrameas
por: Moutsopoulos, Haralampos M.
Publicado: (2022)

Clinical Picture in Hematology
por: Özsoylu, Şinasi
Publicado: (2015)

Is there a place for anti-inflammatory therapy in COVID-19?
por: Yew, Wing Wai, et al.
Publicado: (2020)

Rituximab therapy in Greek patients with rheumatoid arthritis
por: Tsiakalos, Aristotelis P, et al.
Publicado: (2008)

Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use
por: Fragkioudaki, Sofia, et al.
Publicado: (2016)

Finding the right time for anti-inflammatory therapy in COVID-19
por: de Simone, Giovanni, et al.
Publicado: (2020)

An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients
por: Wang, Jing-Zhang, et al.
Publicado: (2020)

Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections?
por: Ch’ng, Ewe Seng, et al.
Publicado: (2020)

Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections
por: Mustafa, Mohd Zulkifli, et al.
Publicado: (2020)

A case of antisynthetase syndrome
por: Mavragani, Clio P., et al.
Publicado: (2020)

Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders
por: Plastiras, Sotiris C, et al.
Publicado: (2021)

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
por: Laskari, Katerina, et al.
Publicado: (2010)

Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients
por: Pelechas, Eleftherios, et al.
Publicado: (2022)

Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection?
por: Kacar, Mark, et al.
Publicado: (2021)

Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape
por: Papa, Alfredo, et al.
Publicado: (2021)

Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study
por: Laskari, Katerina, et al.
Publicado: (2011)

COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?
por: Penlioglou, Theano, et al.
Publicado: (2020)

Anti-tumor necrosis factor treatment in ankylosing spondylitis may not relate to poor prognosis in COVID-19
por: ŞEN, Nesrin, et al.
Publicado: (2020)

Effect of favipiravir and an anti-inflammatory strategy for COVID-19
por: Yamamura, Hitoshi, et al.
Publicado: (2020)

May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?
por: Marasca, Claudio, et al.
Publicado: (2020)

Is Sjögren's syndrome a retroviral disease?
por: Sipsas, Nikolaos V, et al.
Publicado: (2011)

+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications
por: Skarlis, Charalampos, et al.
Publicado: (2021)

Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
por: DiNicolantonio, James J, et al.
Publicado: (2020)

Does use of nonsteroidal anti-inflammatory drugs increase patients’ clinical severity of COVID-19?
por: de Oliveira, Henrique Souza Barros
Publicado: (2021)

Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection
por: Conte, Luana, et al.
Publicado: (2020)

The ARDSnet protocol may be detrimental in COVID-19
por: Tsolaki, Vasiliki, et al.
Publicado: (2020)

The Potential Anti-Inflammatory Effects of Zerumbone in COVID-19 Patients
por: Dehghan, Razieh, et al.
Publicado: (2021)

Hashimoto Thyroiditis, Anti-Parietal Cell Antibodies: Associations With Autoimmune Diseases and Malignancies
por: Boutzios, Georgios, et al.
Publicado: (2022)

It is time to consider an anti-inflammatory therapy based on the pathophysiology of COVID-19 infection during the right time window?
por: Ghanei, Mostafa
Publicado: (2021)

SARS-CoV-2 as Well as Anti-COVID-19 Treatment May Cause Rhabdomyolysis
por: Finsterer, Josef
Publicado: (2021)

Commensal bacterial metabolites may strengthen the effect of anti-IL6 treatment for COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2021)

Correction: Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
Publicado: (2020)

Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19
por: Trojaniello, C., et al.
Publicado: (2021)

Clinical and Laboratory Predictors of Distinct Histopathogical Features of Lupus Nephritis
por: Mavragani, Clio P., et al.
Publicado: (2015)

Gastrointestinal cancer pathways may breakdown due to COVID-19
por: Verma, Ajay M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bng100vudhm19l2dhhg5s36tqq